CI
Cigna Corporation
- Healthcare
- US companies in Healthcare (47)
- NYSE · USD
- Mkt cap $80.8bn
$305.78
as of 26 Oct 2026, 3% below its 52-week high
Screens as well placed to keep growing its dividend, with low cut-risk signals. Its valuation looks somewhat extended against its own history.
These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.
- Trailing yield
- 2.02%Last 12 months of regular payments at today's price
- Forward yield
- 2.02%Each payment expected in the next 12 months, not the latest one doubled
- Earnings cover
- 4.0×Pays 25% of earnings
- Cash cover
- 5.6×Free cash flow over dividends paid
- 5y dividend growth
- Not shownToo large to be ordinary growth, so we leave it out
- Next ex-dividend date
- Estimated4 Dec 2026Quarterly dividend of about $1.51
Compared with US companies in Healthcare (47)
- Trailing yield is higher than 34 of the 46 other US companies in Healthcare.
Quality
90
HighCapacity to keep growing the dividend
Risk
0
LowSignals of dividend-cut pressure
Trim
50
ModerateHow extended the valuation looks
Why Trim is 50
CI against US companies in Healthcare (47)
Valuation against its own history
As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of CI’s past readings.
- P/E11.3×P17, good for this measure
- Yield2.23%P98, good for this measure
- FCF payout17.8%P72, poor for this measure
- Net debt / EBITDA2.04P39, neutral for this measure
- DGR 5y+25.1%P48, neutral for this measure
- ROIC7.7%P86, good for this measure
Forecast your income with the CI dividend calculator
Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.